✦ LIBER ✦

To target or not to target? The costs, benefits, and impacts of indicator-based targeting

✍ Scribed by Nazaire Houssou; Manfred Zeller

Book ID: 113628238
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 462 KB
Volume: 36
Category: Article
ISSN: 0306-9192
DOI: 10.1016/j.foodpol.2011.05.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost benefits of targeting the Pneumococ

Cost benefits of targeting the Pneumococcal Vaccination Program to the elderly population in Taiwan

✍ Yeong-Hwang Chen; Guang-Yang Yang; Ching-Hui Loh; Saou-Hsing Liou; Wen-Lin Su; S 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Using Cost and Health Impacts to Priorit

Using Cost and Health Impacts to Prioritize the Targeted Testing of Tuberculosis in the United States

✍ Thaddeus L. Miller; Peter Hilsenrath; Kristine Lykens; Scott J.N. Mcnabb; Patric 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Can Disease Management Target Patients M

Can Disease Management Target Patients Most Likely to Generate High Costs? The Impact of Comorbidity

✍ Mary Charlson; Robert E. Charlson; William Briggs; James Hollenberg 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

Targeting cardiovascular risk: the impac

Targeting cardiovascular risk: the impact of age, gender and compliance to treatment

✍ Kostapanos, Michael S.; Elisaf, Moses S.; Mikhailidis, Dimitri P. 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 142 KB

To Disclose or Not to Disclose Biracial

To Disclose or Not to Disclose Biracial Identity: The Effect of Biracial Disclosure on Perceiver Evaluations and Target Responses

✍ Diana T. Sanchez; Courtney M. Bonam 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

A Reappraisal of the Risks and Benefits

A Reappraisal of the Risks and Benefits of Treating to Target with Cholesterol Lowering Drugs

✍ Alla, Venkata M.; Agrawal, Vrinda; DeNazareth, Andrew; Mohiuddin, Syed; Ravilla, 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 756 KB